Immune microenvironment modulation unmasks therapeutic benefit of radiotherapy and checkpoint inhibition

Abstract

Overall, this study demonstrates that modulation of the immunosuppressive TIME is required to unlock the benefits of ICIs and radiotherapy to induce immunologic rejection of treatment-refractory established solid tumors.